Alcami Carolinas Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 4260 Forest Park Avenue, St. Louis, Missouri (MO) 63108, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 1942094 · DUNS 117877975
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-10-04
- NAIDrug Quality Assurance2020-01-16
- VAIDrug Quality Assurance2017-03-28
- VAIDrug Quality Assurance2015-01-14
- VAIDrug Quality Assurance2014-01-31
- VAIDrug Quality Assurance2012-02-03
- NAIDrug Quality Assurance2009-11-20
Drugs this plant is listed as making
5 distinct drugs across 13 products name this site in their FDA label.
- buprenorphine hydrochloride, naloxone hydrochlorideIndivior Inc.
- gemcitabine intravesicalJanssen Biotech, Inc
- Magnesium Sulfate in DextroseHospira, Inc.
- morphine sulfatein shortageNortec Development Associates, Inc.
- peramivirBioCryst Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.